CYP8B1
CYP8B1 is a gene that encodes the enzyme sterol 12-alpha-hydroxylase in humans. This enzyme is part of the cytochrome P450 superfamily of enzymes, which are involved in the synthesis and metabolism of various molecules and chemicals within cells. The CYP8B1 enzyme specifically plays a crucial role in the synthesis of bile acids, which are necessary for the digestion and absorption of dietary fats.
Function[edit]
The CYP8B1 gene is located on the short (p) arm of chromosome 3 at position 21.31. The enzyme it encodes, sterol 12-alpha-hydroxylase, is involved in the conversion of cholesterol to bile acids in the liver. This process is part of the larger cholesterol metabolism pathway.
The enzyme catalyzes the 12-alpha-hydroxylation of 4-cholesten-3-one to form cholic acid, one of the primary bile acids. This reaction is a key step in the classic pathway of bile acid synthesis, which is the major pathway for the removal of cholesterol from the body.
Clinical significance[edit]
Mutations in the CYP8B1 gene can lead to a deficiency in the enzyme, which can result in a variety of health problems. These include hypercholesterolemia, a condition characterized by high levels of cholesterol in the blood, and gallstones, which are often formed when there is an imbalance in the composition of bile.
In addition, research has suggested that variations in the CYP8B1 gene may be associated with the risk of developing coronary artery disease, although more studies are needed to confirm this association.
See also[edit]
- Cytochrome P450
- Bile acid
- Cholesterol metabolism
- Hypercholesterolemia
- Gallstones
- Coronary artery disease
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian